Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reneo Pharmaceuticals Inc (NQ: RPHM )

1.760 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.760
Bid (Size) 1.700 (106)
Ask (Size) 1.920 (2)
Prev. Close 1.760
Today's Range 1.760 - 1.760
52wk Range 0.9801 - 11.29
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023
RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Reneo Pharmaceuticals: Q4 Earnings Insights
Via Benzinga

Performance

YTD
+6.02%
+6.02%
1 Month
+6.67%
+6.67%
3 Month
+6.67%
+6.67%
6 Month
-78.87%
-78.87%
1 Year
-80.31%
-80.31%

More News

Read More
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
From Sagimet Biosciences Inc.
Via GlobeNewswire
5 Analysts Have This to Say About Reneo Pharmaceuticals
Via Benzinga
Recap: Reneo Pharmaceuticals Q3 Earnings
Via Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Turns Lower; US Retail Sales Top Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
Via Benzinga
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 3, 2023
Via Benzinga
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.